Andrew J. King
- Co-authors
- John WillanKatie JefferyNicola BienzMelody RedmanDavid KingGraham P. CollinsAndrew PeniketDouglas R. Higgs
- Topics
- Autoimmune Bullous Skin Diseases (3 papers)COVID-19 and healthcare impacts (2 papers)Erythrocyte Function and Pathophysiology (2 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Andrew J. King
22 papers receiving 528 citations
Peers
Comparison fields: 5 of 108
- Oncology 134
- Molecular Biology 123
- Infectious Diseases 88
- General Health Professions 76
- Epidemiology 69
Countries citing papers authored by Andrew J. King
This map shows the geographic impact of Andrew J. King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew J. King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew J. King more than expected).
Fields of papers citing papers by Andrew J. King
This network shows the impact of papers produced by Andrew J. King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew J. King. The network helps show where Andrew J. King may publish in the future.
Co-authorship network of co-authors of Andrew J. King
This figure shows the co-authorship network connecting the top 25 collaborators of Andrew J. King. A scholar is included among the top collaborators of Andrew J. King based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew J. King. Andrew J. King is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 58 | |
| 5 | 174 | |
| 6 | 14 | |
| 7 | 17 | |
| 8 | 15 | |
| 9 | 132 | |
| 10 | 5 | |
| 11 | 10 | |
| 12 | 3 | |
| 13 | 5 | |
| 14 | 19 | |
| 15 | 2 | |
| 16 | 46 | |
| 17 | 18 | |
| 18 | 1 | |
| 19 | 2 | |
| 20 | 1 |
About Andrew J. King
Andrew J. King is a scholar working on Business and International Management, Hematology and Pathology and Forensic Medicine, having authored 22 papers that have together received 548 indexed citations. Recurring topics across this work include Autoimmune Bullous Skin Diseases (3 papers), COVID-19 and healthcare impacts (2 papers) and Erythrocyte Function and Pathophysiology (2 papers). The work is most often cited by research in Business and International Management (14 citations), Genetics (56 citations) and Oncology (134 citations). Andrew J. King has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include John Willan, Katie Jeffery, Nicola Bienz, Melody Redman, David King, Graham P. Collins, Andrew Peniket, Douglas R. Higgs, Luis A. Díaz and Gerald N. Levy. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Journal of the American Society of Nephrology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.